Physician profile
Eric L Pacini
NPI 1043420086
$1,020.28
in general payments reported to CMS, 2019-2025
17 companies · $50.77 in 2025
The $50.77 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $81.45 · 2021: $88.06 · 2022: $20.00 · 2023: $183 · 2024: $349 · 2025: $50.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.23 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $228.34 | 2019-2024 | Andexxa, Farxiga, Lokelma |
| Novartis Pharmaceuticals Corporation | $180.05 | 2019-2025 | |
| Boston Scientific Corporation | $109.96 | 2021-2024 | Versacross Access Solution, Versacross Large Access Solution |
| Amgen INC. | $101.35 | 2019-2024 | Repatha |
| Kiniksa Pharmaceuticals International, Plc | $74.21 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $63.45 | 2019-2024 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $50.99 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amarin Pharma, INC. | $36.68 | 2019-2020 | |
| Philips North America LLC | $28.46 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.71 | 2019 | |
| Terumo Medical Corporation | $22.85 | 2024 | Angio-Seal |
| Cvrx, INC. | $22.50 | 2024 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $20.00 | 2022 | |
| Abbott Laboratories | $19.40 | 2019 | |
| Alnylam Pharmaceuticals INC. | $16.46 | 2023 | Amvuttra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $15.75 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pacini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.